---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285243186.md"
description: "In Tuesday's intraday session, several health care stocks experienced significant movements. Viridian Therapeutics (VRDN) surged 30.7% to $18.37, while Biodesix (BDSX) rose 29.37% to $14.58. Other gainers included Biodexa Pharmaceuticals (BDRX) up 27.24%, Fortrea Holdings (FTRE) up 25.14%, and Cellectar Biosciences (CLRB) up 24.13%. Conversely, Embecta (EMBC) plummeted 55.2% to $4.14, GeneDx Holdings (WGS) fell 49.81% to $34.09, and Picard Medical (PMI) decreased 41.2% to $0.21. Overall, the session highlighted notable volatility in health care stocks."
datetime: "2026-05-05T17:05:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285243186.md)
  - [en](https://longbridge.com/en/news/285243186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285243186.md)
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **Viridian Therapeutics** (NASDAQ:VRDN) shares rose 30.7% to $18.37 during Tuesday's regular session. The company's market cap stands at $1.4 billion. As per the press release, Q1 earnings came out today.
-   **Biodesix** (NASDAQ:BDSX) shares rose 29.37% to $14.58. The company's market cap stands at $90.1 million. As per the press release, Q1 earnings came out yesterday.
-   **Biodexa Pharmaceuticals** (NASDAQ:BDRX) shares increased by 27.24% to $3.97. The company's market cap stands at $10.1 million.
-   **Fortrea Holdings** (NASDAQ:FTRE) shares increased by 25.14% to $15.33. The company's market cap stands at $1.1 billion. The company's, Q1 earnings came out today.
-   **Cellectar Biosciences** (NASDAQ:CLRB) shares rose 24.13% to $3.51. The company's market cap stands at $11.9 million.
-   **Lixte Biotechnology Hldgs** (NASDAQ:LIXT) shares moved upwards by 23.1% to $4.05. The market value of their outstanding shares is at $38.2 million.

### Losers

-   **Embecta** (NASDAQ:EMBC) shares fell 55.2% to $4.14 during Tuesday's regular session. The market value of their outstanding shares is at $547.7 million. As per the press release, Q2 earnings came out today.
-   **GeneDx Holdings** (NASDAQ:WGS) stock declined by 49.81% to $34.09. The company's market cap stands at $1.9 billion. As per the press release, Q1 earnings came out yesterday.
-   **Picard Medical** (AMEX:PMI) shares decreased by 41.2% to $0.21. The company's market cap stands at $26.5 million.
-   **Akanda** (NASDAQ:AKAN) stock decreased by 36.31% to $26.16. The market value of their outstanding shares is at $21.9 million.
-   **Onconetix** (NASDAQ:ONCO) stock decreased by 20.22% to $0.52. The market value of their outstanding shares is at $7.4 million.
-   **Ocugen** (NASDAQ:OCGN) shares decreased by 19.19% to $1.5. The company's market cap stands at $626.2 million. As per the press release, Q1 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [EMBC.US](https://longbridge.com/en/quote/EMBC.US.md)
- [FTRE.US](https://longbridge.com/en/quote/FTRE.US.md)
- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [WGS.US](https://longbridge.com/en/quote/WGS.US.md)
- [CLRB.US](https://longbridge.com/en/quote/CLRB.US.md)
- [BDSX.US](https://longbridge.com/en/quote/BDSX.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [LIXT.US](https://longbridge.com/en/quote/LIXT.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)
- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)
- [WGSWW.US](https://longbridge.com/en/quote/WGSWW.US.md)

## Related News & Research

- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Leerink Partners Reiterates "Market Perform" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)](https://longbridge.com/en/news/286773280.md)
- [Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS](https://longbridge.com/en/news/285781611.md)
- [Viridian Therapeutics REVEAL-2 Hits Phase 3 Endpoint, Shows “IV-like” Proptosis Gains in Chronic TED](https://longbridge.com/en/news/285337358.md)